ArticleOncotarget2017

Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.

Yu-Chieh Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.